Kestine tablets film-coated

国家: 亚美尼亚

语言: 英文

来源: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

产品特点 产品特点 (SPC)
23-09-2022

有效成分:

ebastine

可用日期:

Industrias Farmaceuticas Almirall S.A.

ATC代码:

R06AX22

INN(国际名称):

ebastine

剂量:

10mg

药物剂型:

tablets film-coated

每包单位数:

(5/1x5/) in blister, (10/1x10/) in blister

处方类型:

Prescription

授权状态:

Registered

授权日期:

2022-09-23

产品特点

                                1/7
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
Kestine 10 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 10 mg of ebastine.
EXCIPIENT WITH KNOWN EFFECT:_ _Each film-coated tablet contains 88.5
mg of lactose.
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Film-coated tablet.
The film-coated tablets are white to almost white, round, engraved
with “E/10” on one side.
The engraved line is not intended for breaking the tablet.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Kestine is indicated in the symptomatic treatment of:
•
allergic rhinitis (seasonal and perennial) associated or not with
allergic conjunctivitis
•
urticaria of different etiology including idiopathic chronic urticaria
4.2 POSOLOGY AND
METHOD OF
ADMINISTRATION
_Posology _
ADULTS AND CHILDREN OVER 12 YEARS OF AGE
The recommended dose is 10 mg of ebastine once daily. If the effect is
not sufficient, it is
advised to take two tablets of Kestine 10 mg, once daily.
ELDERLY PATIENTS
It is no necessary to adjust the dose.
RENAL INSUFFICIENCY
It is not necessary to adjust the dose in patients with mild, moderate
or
severe renal
insufficiency.
HEPATIC INSUFFICIENCY
It is not necessary to adjust the dose in patients with mild or
moderate hepatic impairment
(Child-Pugh Classes A and B). There is no experience with doses over
10 mg in patients with
2/7
severe
hepatic
insufficiency
(Child-Pugh
Class
C);
therefore,
the
dose
of
10
mg
of
ebastine/day should not be exceeded in these patients.
Treatment may be prolonged until symptoms disappear.
_Method of administration _
For oral use.
The tablets may be taken with or without food and with a glass of
water.
4.3 CONTRAINDICATIONS
Known hypersensitivity to the active substance or to any excipient
listed in section 6.1.
Pregnancy, lactation period, children under 12 years of age, deficit
of lactase, intolerance of
lactose, malabsorption of glucose-galactose.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Adm
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 俄文 23-09-2022

搜索与此产品相关的警报